Effect of nonsteroidal anti-inflammatory drugs on stage of colon cancer at diagnosis

Journal of Clinical Epidemiology

Volumn 56, Issue 8, 2003, Pages 782-787

  Benedetti, Andrea L ^a,b,c   Collet, Jean Paul ^a,b   Boivin, Jean Francois ^a,b   Hanley, James A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Anti inflammatory agents; Colon neoplasms; Epidemiology; Neoplasm staging; Nonsteroidal

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTECTIVE AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; COLON CANCER; CONFIDENCE INTERVAL; DATA BASE; DISEASE SEVERITY; DRUG EXPOSURE; DRUG USE; HUMAN; METASTASIS; PRIORITY JOURNAL; PROTECTION; REGISTER; STATISTICAL SIGNIFICANCE;

EID: 0041382838     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(03)00131-8     Document Type: Article

References (26)

1. International Agency for Research on Cancer. IARC Scientific Publications No. 121. Trends in Cancer Incidence and Mortality. 1993;IARC, Lyon.
2. Landis S.H., Murray T., Bolden S., et al. Cancer statistics, 1999. CA Cancer J Clin. 49:1999;8-31.
3. Berkel H.J., Holcombe R.F., Middlebrooks M., et al. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev. 18:1996;205-215.
4. Peleg I.I., Maibach H.T., Brown S.H., et al. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med. 154:1994;394-399.
5. Rosenberg L., Palmer J.R., Zauber A.G., et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 83:1991;355-359.
6. Muscat J.E., Stellman S.D., Wynder E.L. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer. 74:1994;1847-1854.
7. Kune G.A., Kune S., Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48:1988;4399-4404.
8. Thun M.J., Namboodiri M.M., Heath C.W. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 325:1991;1593-1596.
9. Suh O., Mettlin C., Petrelli N.J. Aspirin use, cancer, and polyps of the large bowel. Cancer. 72:1993;1171-1172.
10. Collet J.P., Sharpe C., Belzile E., et al. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer. 81:1999;62-68.
11. Giovannucci E., Egan K.M., Hunter D.J., et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 333:1995;610-614.
12. Giovannucci E., Rimm E., Stampfer M.J., et al. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 121:1994;241-246.
13. Paganini-Hill A., Chao A., Ross R.K., et al. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 299:1989;1250.
14. Screinemachers D.M., Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 5:1994;146.
15. Thun M.J., Namboodiri M.M., Calle E.E., et al. Aspirin use and risk of fatal cancer. Cancer Res. 53:1993;1322-1327.
16. Gann P.H., Manson J.E., Buring J.E., et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 85:1993;1220-1224.
17. Thun M.J. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin North Am. 25:1996;333-347.
18. Sharpe C., Collet J.P., McNutt M., et al. Nested case-control study of the effects non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer. 83:2000;112-120.
19. Gore R.M. Colorectal cancer: clinical and pathologic features. Radiol Clin North Am. 35:1997;403-426.
20. Bosman F.T. Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer. 31A:1995;1216-1221.
21. Risch H.A., Howe G.R. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am J Epidemiol. 139:2000;670-683.
22. Kelley W.N. Textbook of internal medicine. 2nd edition:1992;JB Lippincott, Philadelphia.
23. Annual statistical report 1995-1996. Prescription drug services branch. 2000;Saskatchewan Health, Regina, Saskatchewan.
24. Scott S.C., Goldberg M.S., Mayo N.E. Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol. 50:1997;45-55.
25. Breslow N.E., Day N.E. Statistical methods in cancer research. Volume 1: the analysis of case-control studies. 1980;International Agency for Research on Cancer, Lyon.
26. Rothman K.J. Induction and latent periods. Am J Epidemiol. 114:1981;253-259.